1. AF.81 NONINVASIVE ASSESSMENTS TO IDENTIFY PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH: SCREENED POPULATION FROM THE REGENERATE TRIAL. (September 2021) Authors: Petta, S.; Boursier, J.; Sanyal, A.J.; Ratziu, V.; Rinella, M.; Loomba, R.; Dufour, J.; Granston, T.; Zhou, H.; Trylesinski, A.; Harrison, S.A.; Bedossa, P.; Goodman, Z.; Younossi, Z.; Noureddin, M.; Bugianesi, E.; Anstee, Q.M. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of treatment response in non‐alcoholic steatohepatitis using advanced magnetic resonance imaging. Issue 6 (24th January 2017) Authors: Lin, S. C.; Heba, E.; Bettencourt, R.; Lin, G. Y.; Valasek, M. A.; Lunde, O.; Hamilton, G.; Sirlin, C. B.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 6(2017) Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association between novel MRI‐estimated pancreatic fat and liver histology‐determined steatosis and fibrosis in non‐alcoholic fatty liver disease. Issue 6 (5th February 2013) Authors: Patel, N. S.; Peterson, M. R.; Brenner, D. A.; Heba, E.; Sirlin, C.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 6(2013) Page Start: 630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis. Issue 5 (14th January 2018) Authors: Hameed, B.; Terrault, N. A.; Gill, R. M.; Loomba, R.; Chalasani, N.; Hoofnagle, J. H.; Van Natta, M. L. Other Names: Allende Daniela investigator.; Dasarathy Srinivasan investigator.; J. McCullough Arthur investigator.; Penumatsa Revathi investigator.; Dasarathy Jaividhya investigator.; E. Lavine Joel investigator.; F. Abdelmalek Manal investigator.; Bashir Mustafa investigator.; Buie Stephanie investigator.; M... Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 5(2018) Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical, biochemical and histological differences between HIV‐associated NAFLD and primary NAFLD: a case–control study. Issue 4 (11th December 2014) Authors: Vodkin, I.; Valasek, M. A.; Bettencourt, R.; Cachay, E.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 4(2015) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Commentary: dissecting the PNPLA3 association with liver fat and stiffness, and interaction with diet. Issue 8 (April 2014) Authors: Stinton, L.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 39:Issue 8(2014) Page Start: 894 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Commentary: non‐alcoholic fatty pancreas ‐ toward an uncharted territory; authors' reply. Issue 9 (3rd April 2013) Authors: Patel, N. S.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 37:Issue 9(2013) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study. Issue 12 (15th April 2015) Authors: Cui, J.; Ang, B.; Haufe, W.; Hernandez, C.; Verna, E. C.; Sirlin, C. B.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 12(2015) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Editorial: call to screen for NAFLD and NASH in psoriasis. Issue 5 (March 2015) Authors: Verna, E. C.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 5(2015) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Editorial: dark chocolate may improve NAFLD and metabolic syndrome by reducing oxidative stress. Issue 5 (3rd August 2016) Authors: Malhi, H.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 5(2016) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗